Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
Public ClinicalTrials.gov record NCT00518895. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind Study of Dacarbazine With or Without Genasense in Chemotherapy-naive Subjects With Advanced Melanoma and Low LDH (The AGENDA Trial)
Study identification
- NCT ID
- NCT00518895
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Genta Incorporated
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- dacarbazine plus Genasense Drug
- dacarbazine plus placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2007
- Primary completion
- Apr 30, 2011
- Completion
- Apr 30, 2011
- Last update posted
- Nov 6, 2011
2007 – 2011
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama Hospital, Mitchell Cancer Institute | Mobile | Alabama | 36607 | — |
| San Diego Pacific Oncology and Hematology Associates Inc. | Encinitas | California | 92024 | — |
| Redwood Regional Medical Group, Inc. | Santa Rosa | California | 95403 | — |
| Siouxland Hematology Oncology Associates | Sioux City | Iowa | 51101 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Hematology Oncology Centers of the Northern Rockies | Billings | Montana | 59101 | — |
| Morristown Memorial - Atlantic Healthcare System | Morristown | New Jersey | 07960 | — |
| Cancer Care Associates | Oklahoma City | Oklahoma | 73112 | — |
| Cancer Care Associates, Site 1 | Tulsa | Oklahoma | 74104 | — |
| St. Luke's Cancer Center | Bethlehem | Pennsylvania | 18015 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
| Texas Oncology - Sammons Cancer Center | Dallas | Texas | 75246 | — |
| MD Anderson Cancer Center at University of Texas | Houston | Texas | 77030-4009 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00518895, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2011 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00518895 live on ClinicalTrials.gov.